Akimasa Nakao

Akimasa Nakao


Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Annals of Surgery
Verified
Journal Article
Closed access
ANAkimasa Nakao
Akimasa Nakao
AKAkiyuki Kanzaki
Akiyuki Kanzaki
TFTsutomu Fujii
Tsutomu Fujii
YKYasuhiro Kodera
Yasuhiro Kodera
SYSuguru Yamada
Suguru Yamada
STShin Takeda
Shin Takeda
Objectives A retrospective study was performed to clarify the correlation between radiographic type of portal vein (PV) invasion and pathological grade of PV wall invasion, and their correlation with postoperative prognosis. Background: In many patients with pancreatic cancer, PV resection is necessary to increase resectability and obtain cancer-free margins. Methods: We analyzed 671 patients who had undergone surgery for invasive adenocarcinoma of the pancreas between July 1981 and June 2010. Radiographic types of PV invasion of pancreatic head cancer were classified into A (normal), B (unilateral narrowing), C (bilateral narrowing), or D (complete obstruction with collateral veins), by portography or computed tomography. Pathological grades of PV wall invasion were classified as 0 (no invasion), 1 (tunica adventitia), 2 (tunica media), or 3 (tunica intima). Results: Four hundred and sixty-three patients underwent resection, and PV resection was performed in 297. Combined arterial vessel resection was performed in 16 cases. No significant difference in operative mortality was observed between PV preservation (0.6%) and PV-only resection (2.1%), and no operative deaths occurred after 1999. Radiographic classification of PV invasion correlated with incidence of pathological PV wall invasion. In pancreatic head carcinoma, no pathological PV wall invasion was observed in type A (n = 111). Pathological PV invasion was observed in 51% of type B (42/82), 74% of type C (72/97), and 93% of type D (63/68). Long-term survival (>5 years) was observed in types A and B, and grades 0 and 1 subgroups. Conclusions: Pancreatectomy with PV resection can be performed safely. Even in radiographic classification type B, pathological PV wall invasion was observed in 51% of patients. Long-term survival was observed in types A and B, and grades 0 and 1.

10 May 2006 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
ANAkimasa Nakao
Akimasa Nakao
STShin Takeda
Shin Takeda
SISoichiro Inoue
Soichiro Inoue
SNShuji Nomoto
Shuji Nomoto
NKNaohito Kanazumi
Naohito Kanazumi
TFTsutomu Fujii
Tsutomu Fujii

24 July 2006 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
HKHideto Kimata
Hideto Kimata
TITsuneo Imai
Tsuneo Imai
TKToyone Kikumori
Toyone Kikumori
OTOsamu Teshigahara
Osamu Teshigahara
TNTetsuro Nagasaka
Tetsuro Nagasaka
ANAkimasa Nakao
Akimasa Nakao

1 April 2004 in Pancreas
Verified
Journal Article
Closed access
ANAkimasa Nakao
Akimasa Nakao
STShin Takeda
Shin Takeda
MSMitsuru Sakai
Mitsuru Sakai
TKTetsuya Kaneko
Tetsuya Kaneko
SISoichiro Inoue
Soichiro Inoue
NKNaohito Kanazumi
Naohito Kanazumi
This clinical study was carried out to clarify the indications for extended radical resection for pancreatic carcinoma. From July 1981 to September 2003, 250 of 391 (63.9%) patients with pancreatic carcinoma underwent tumor resection in our department. Portal vein resection was performed in 171 of these 250 (68.4%) resected cases. The postoperative survival rate was studied using the operative and histologic findings. Most of the patients who survived for 2 or 3 years were in the carcinoma-free surgical margins group. The most important indication for an extended radical resection combined with portal vein resection for pancreatic cancer is the ability to obtain surgical cancer-free margins. There is no indication for an extended resection in patients in whom the surgical margins will become cancer positive if such an operation is employed.

1 January 2009 in Pancreas
Verified
Journal Article
Closed access
SYSuguru Yamada
Suguru Yamada
ANAkimasa Nakao
Akimasa Nakao
TFTsutomu Fujii
Tsutomu Fujii
HSHiroyuki Sugimoto
Hiroyuki Sugimoto
NKNaohito Kanazumi
Naohito Kanazumi
STShin Takeda
Shin Takeda
Objectives: The purpose of this study was to determine the operative indications for pancreatic cancer with paraaortic lymph node metastases (No. 16 [+]). Methods: Between July 1981 and March 2007, 335 patients with pancreatic cancer including 45 No. 16 (+) patients underwent extended radical surgery at the Department of Surgery II, Nagoya University. The overall survival rates and clinicopathological parameters were analyzed using univariate and multivariate analyses. Results: Although there was no significant difference in survival between the No. 16 (+) patients and the unresectable cases, there were some long-term survivors among the No. 16 (+) patients. Multivariate analysis of the No. 16 (+) patients identified age (59 years or younger), tumor size (>4 cm), and pathologically confirmed portal invasion (pPV[+]) as independent prognostic factors. The survival of No. 16 (+) patients without these factors was significantly better than the unresectable cases. The survival of patients with only 1 metastatic paraaortic lymph node also was significantly better than the unresectable cases, and tended to be better than those with more than 2 metastatic nodes. Conclusions: No. 16 (+) pancreatic cancer patients with age 60 years or older, tumor size 4 cm or less, and pPV(−) may benefit from resection.

1 January 2006 in World Journal of Gastroenterology
Verified
Journal Article
Open access
ANAkimasa Nakao
Akimasa Nakao
TFTsutomu Fujii
Tsutomu Fujii
HSHiroyuki Sugimoto
Hiroyuki Sugimoto
NKNaohito Kanazumi
Naohito Kanazumi
SNShuji Nomoto
Shuji Nomoto
STShin Takeda
Shin Takeda
Despite the development of more sophisticated diagnostic techniques, pancreatic carcinoma has not yet been detected in the early stage. Surgical resection provides the only chance for cure or long-term survival. The resection rate has increased due to recent advances in surgical techniques and the application of extensive surgery. However, the postoperative prognosis has been poor due to commonly occurring liver metastasis, local recurrence and peritoneal dissemination. Recent molecular-biological studies have clarified occult metastasis, micrometastasis and systemic disease in pancreatic cancer. Several oncological problems in pancreatic cancer surgery are discussed in the present review.